Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Sponsors » Next-Generation Discovery Workflows » Epigenome Study Maps Hydroxymethylation Across Diverse Human Tissue Types

Epigenome Study Maps Hydroxymethylation Across Diverse Human Tissue Types

Dec 02, 2020
|
staff reporter

NEW YORK – Researchers at the University of Chicago, Bluestar Genomics, and elsewhere have developed a genome-wide tissue map of the DNA 5-hydroxymethylcytosine (5hmC) modification that revealed its role in tissue-specific development and as a potential diagnostic and prognostic biomarker for a variety of human diseases.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Breathe It Out

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

The Next Batch

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Switch for the Second

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.

Science Reviews How Non-Genetic DNA Features Expand Utility of Liquid Biopsies, Presents Study of Enzymes in DNA Methylation

In Science this week: review discusses advances in liquid biopsies, and more.

Apr
20
Featured Webinar

Analysis of a Wellness Cohort Identifies Markers of Metastatic Cancer Years Prior to Diagnosis

Sponsored by
Olink

This webinar will discuss a study that sought to identify early biomarkers for cancer by analyzing pre-diagnosis samples from seemingly healthy individuals who were later diagnosed with cancer.

What's Popular?

In Epigenetics Research

  1. Epigenetic Biomarker Firm Foxo Technologies Raises $10M

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.